💡 在您使用本产品前请认真阅读说明书,这对您顺利完成实验很有帮助。
|
🏷️ 产品编码
RB9T37017360
|
🧬 中文名称
埃诺比利妥珠单抗ELISA检测试剂盒
|
|
📝 英文名称
Enoblituzumab ELISA Kit
| |
|
🔬 应用
ELISA
| |
|
🔢 登录号
Q5ZPR3
|
🔹 靶标
埃诺比利妥珠单抗酶联免疫检测试剂盒
|
|
🔹 检测方法
Colorimetric
|
🔹 灵敏度
0.156 μg/ml
|
|
🔹 检测范围
0.31-5 μg/mL
|
🔹 回收率
80-120%
|
|
🔹 样本类型
Plasma, Serum
|
🔹 检测类型
Quantitative
|
|
🔹 背景信息
Enoblituzumab (also referred to as MGA271) is an Fc optimized humanized IgG1 monoclonal antibody that binds to B7-H3 (CD276), a member of the B7 family. This drug was developed by MacroGenics, Inc. that can be potentially used in the treatment of Solid tumors. Enoblituzumab is Fc-engineered with 5 amino acid substitutions to enhance binding to the activating FcγR and decrease binding to the inhibitory FcγR. Pre-clinical studies show that, in human CD16A-bearing transgenic mice, MGA271 exhibited potent antitumor activity in B7-H3–expressing xenograft models of renal cell and bladder carcinoma. To date, approximately 180 patients have received enoblituzumab monotherapy in a phase I study, with good tolerability. To determine the anti-tumor, immunological and biological effects of B7-H3 inhibition in high-risk localized pancreatic cancer, MacroGenics is currently conducting a neoadjuvant and pharmacodynamic phase II study.
| |
|
🏷️ 别名
MG-A271, , 1353485-38-7
| |
❄️ 稳定性和储存
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
🚚 运输条件
2-8 ℃
⚠️ For Research Use Only.